Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.43 |
| ▸ | GRIN2D | O15399 | 2/20 | 0.40 |
| ▸ | GRIN3B | O60391 | 2/20 | 0.40 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.40 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.40 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.40 |
| ▸ | GRIN2C | Q14957 | 2/20 | 0.40 |
| ▸ | GRIN3A | Q8TCU5 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | IDO1 | P14902 | 2/20 | 0.37 |
| ▸ | AGXT | P21549 | 2/20 | 0.37 |
| ▸ | NQO2 | P16083 | 1/20 | 0.37 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29738341 | 1.00 | CYP19A1 (0.50) | CYP19A1ALDH1A1CYP3A4PTGS2GRIN2D | |
| SCHEMBL11258820 | 0.84 | ALDH1A1 (0.53) | CYP19A1ALDH1A1CYP3A4PTGS2GRIN2D | |
| SCHEMBL88823 | 0.84 | ALDH1A1 (0.61) | CYP19A1ALDH1A1CYP3A4PTGS2GRIN2D | |
| SCHEMBL30380963 | 0.83 | CYP19A1 (0.56) | CYP19A1ALDH1A1CYP3A4PTGS2GRIN2D | |
| SCHEMBL20098971 | 0.83 | CYP19A1 (0.56) | CYP19A1ALDH1A1CYP3A4PTGS2GRIN2D | |
| SCHEMBL3507655 | 0.83 | CYP19A1 (0.50) | CYP19A1ALDH1A1CYP3A4GRIN2DGRIN3B | |
| SCHEMBL4976688 | 0.81 | CYP19A1 (0.48) | CYP19A1ALDH1A1CYP3A4PTGS2GRIN2D | |
| SCHEMBL6252024 | 0.81 | CYP19A1 (0.48) | CYP19A1ALDH1A1CYP3A4PTGS2GRIN2D | |
| SCHEMBL15805540 | 0.81 | CYP19A1 (0.48) | CYP19A1ALDH1A1CYP3A4GRIN2DGRIN3B | |
| SCHEMBL28793846 | 0.81 | CYP19A1 (0.48) | CYP19A1ALDH1A1CYP3A4GRIN2DGRIN3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9249091-B2 | Post-treated sulfurized salt of an alkyl-substituted hydroxyaromatic composition | CHEVRON ORONITE COMPANY LLC (US) | 2016-02-02 | — | — | US | claimed |
| US-20130165359-A1 | POST-TREATED SULFURIZED SALT OF AN ALKYL-SUBSTITUTED HYDROXYAROMATIC COMPOSITION | CHEVRON ORONITE COMPANY LLC (US) | 2013-06-27 | — | — | US | claimed |
| US-7056986-B2 | ethylene monomer can be a vinyl ketone, ether, ester, halide, nitrile, aromatic, or an allyl ether; acrylic monomer can be a mono- or diacid or monoester of a diacid; a monoamine, a guanidine compound, and an aromatic diamine; improved vulcanizability, balance between processability and compression set | DENKI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 2006-06-06 | — | — | US | claimed |
| CN-110249004-B | Polyimide precursor composition | 东京应化工业株式会社 | 2022-07-19 | — | — | CN | disclosed |
| CN-108774561-B | Sulfurized salts of post-treated alkyl-substituted hydroxyaromatic compositions | 雪佛龙奥伦耐有限责任公司 | 2022-07-01 | — | — | CN | disclosed |
| CN-108389512-B | Laminate, flexible device, and method for producing laminate | 东京应化工业株式会社 | 2022-04-15 | — | — | CN | disclosed |
| CN-108387954-B | Laminate, flexible device, and method for producing laminate | 东京应化工业株式会社 | 2022-01-18 | — | — | CN | disclosed |
| WO-2021207790-A1 | METHOD OF PROPHYLAXIS OF CORONAVIRUS AND/OR RESPIRATORY SYNCYTIAL VIRUS INFECTION | STARPHARMA PTY LTD (AU) | 2021-10-21 | — | — | WO | disclosed |
| EP-3896058-A2 | ENANTIONSELECTIVE PROCESSES TO INSECTICIDAL 3-ARYL-3-TRIFLUOROMETHYL-SUBSTITUTED PYRROLIDINES | SYNGENTA PARTICIPATIONS AG (CH) | 2021-10-20 | — | — | EP | disclosed |
| US-10954340-B2 | Polyimide precursor composition | TOKYO OHKA KOGYO CO., LTD. (JP) | 2021-03-23 | — | — | US | disclosed |
| CN-107922733-B | Polyimide precursor composition | 东京应化工业株式会社 | 2020-09-11 | — | — | CN | disclosed |
| EP-3330320-B1 | POLYIMIDE PRECURSOR COMPOSITION | TOKYO OHKA KOGYO CO LTD (JP) | 2019-04-24 | — | — | EP | disclosed |
| US-20180223045-A1 | POLYIMIDE PRECURSOR COMPOSITION | TOKYO OHKA KOGYO CO., LTD. (JP) | 2018-08-09 | — | — | US | disclosed |
| EP-3330320-A1 | POLYIMIDE PRECURSOR COMPOSITION | Tokyo Ohka Kogyo Co., Ltd. (JP) | 2018-06-06 | — | — | EP | disclosed |
| US-9249091-B2 | Post-treated sulfurized salt of an alkyl-substituted hydroxyaromatic composition | CHEVRON ORONITE COMPANY LLC (US) | 2016-02-02 | — | — | US | disclosed |
| EP-1449881-B1 | ACRYLIC RUBBER COMPOSITION | DENKI KAGAKU KOGYO KK (JP) | 2014-06-18 | — | — | EP | disclosed |
| US-20130165359-A1 | POST-TREATED SULFURIZED SALT OF AN ALKYL-SUBSTITUTED HYDROXYAROMATIC COMPOSITION | CHEVRON ORONITE COMPANY LLC (US) | 2013-06-27 | — | — | US | disclosed |
| US-7056986-B2 | ethylene monomer can be a vinyl ketone, ether, ester, halide, nitrile, aromatic, or an allyl ether; acrylic monomer can be a mono- or diacid or monoester of a diacid; a monoamine, a guanidine compound, and an aromatic diamine; improved vulcanizability, balance between processability and compression set | DENKI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 2006-06-06 | — | — | US | disclosed |
| US-20040266922-A1 | Ethylene-acrylic copolymer rubber composition | DENKI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 2004-12-30 | — | — | US | disclosed |
| EP-1449881-A1 | ACRYLIC RUBBER COMPOSITION | DENKI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 2004-08-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130165359-A1 | POST-TREATED SULFURIZED SALT OF AN ALKYL-SUBSTITUTED HYDROXYAROMATIC COMPOSITION | TST, PAH, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | CYP19A1 1923/4885ALDH1A1 814/4885CYP3A4 2118/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.